纳米铁酸钴
|
C683798-10g
|
≥98%, <100nm |
12052-28-7 |
10g
|
¥ 159.9
|
现货 |
阿拉丁 |
1-(2-溴乙氧基)-2-(2-甲氧基乙氧基)乙烷
|
B683564-5g
|
≥95% |
72593-77-2 |
5g
|
¥ 269.9
|
现货 |
阿拉丁 |
1-(2-溴乙氧基)-2-(2-甲氧基乙氧基)乙烷
|
B683564-1g
|
≥95% |
72593-77-2 |
1g
|
¥ 56.9
|
现货 |
阿拉丁 |
Boc-Gly-Gly-Phe-Gly-OH
|
B412456-5g
|
≥97% |
187794-49-6 |
5g
|
¥ 2499.9
|
期货,请咨询 |
阿拉丁 |
Boc-Gly-Gly-Phe-Gly-OH
|
B412456-250mg
|
≥97% |
187794-49-6 |
250mg
|
¥ 299.9
|
期货,请咨询 |
阿拉丁 |
Boc-Gly-Gly-Phe-Gly-OH
|
B412456-1g
|
≥97% |
187794-49-6 |
1g
|
¥ 799.9
|
期货,请咨询 |
阿拉丁 |
Boc-Gly-Gly-Phe-Gly-OH
|
B412456-100mg
|
≥97% |
187794-49-6 |
100mg
|
¥ 199.9
|
期货,请咨询 |
阿拉丁 |
乙酰乙酸烯丙酯
|
A683469-500g
|
≥96% |
1118-84-9 |
500g
|
¥ 319.9
|
现货 |
阿拉丁 |
乙酰乙酸烯丙酯
|
A683469-25g
|
≥96% |
1118-84-9 |
25g
|
¥ 29.9
|
现货 |
阿拉丁 |
乙酰乙酸烯丙酯
|
A683469-100g
|
≥96% |
1118-84-9 |
100g
|
¥ 79.9
|
现货 |
阿拉丁 |
三丁基(氰甲基)氯化鏻
|
T683560-1g
|
≥95%(T) |
82358-61-0 |
1g
|
¥ 75.9
|
现货 |
阿拉丁 |
4-正丙基苯甲酰氯
|
P670390-1g
|
≥95% |
52710-27-7 |
1g
|
¥ 39.9
|
现货 |
阿拉丁 |
硫酸葡聚糖钠盐
|
D491166-10K-5g
|
|
9011-18-1 |
5g
|
¥ 2059.9
|
现货 |
阿拉丁 |
二(三甲基硅基)烯丙基胺
|
N640169-5g
|
≥90% |
7688-51-9 |
5g
|
¥ 319.9
|
现货 |
阿拉丁 |
二(三甲基硅基)烯丙基胺
|
N640169-25g
|
≥90% |
7688-51-9 |
25g
|
¥ 1269.9
|
现货 |
阿拉丁 |
4-氯乙酰乙酸甲酯
|
M683347-100ml
|
≥90%(GC) |
32807-28-6 |
100ml
|
¥ 89.9
|
现货 |
阿拉丁 |
3-癸烯-2-酮
|
D683407-1ml
|
≥90% |
10519-33-2 |
1ml
|
¥ 39.9
|
现货 |
阿拉丁 |
苯甲酸苄酯
|
B683409-10L
|
≥94% |
120-51-4 |
10L
|
¥ 599.9
|
现货 |
阿拉丁 |
邻苯基苯氧乙基丙烯酸酯
|
B590707-5g
|
≥97%, stabilized with MEHQ |
91442-24-9 |
5g
|
¥ 999.9
|
现货 |
阿拉丁 |
Vonlerolizumab (anti-OX40)
|
Ab175702-100μg
|
Moligand™, RUO, ≥95%(SDS-PAGE&SEC), Lot by Lot |
1638935-72-4 |
100μg
|
¥ 629.9
|
现货 |
阿拉丁 |
Trastuzumab emtansine (anti-ERBB2)
|
Ab175686-100μg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1018448-65-1 |
100μg
|
¥ 919.9
|
期货,请咨询 |
阿拉丁 |
Tisotumab vedotin (anti-Tissue Factor)
|
Ab175681-100μg
|
ExactAb™, 重组, 已验证, 无叠氮钠, 低内毒素, 无载体, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1418731-10-8 |
100μg
|
¥ 1509.9
|
现货 |
阿拉丁 |
Rovelizumab (anti-CD11a&CD18)
|
Ab175649-100μg
|
ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
339086-79-2 |
100μg
|
¥ 669.9
|
期货,请咨询 |
阿拉丁 |
Ozoralizumab (anti-TNF-alpha&HSA)
|
Ab175623-100μg
|
Carrier Free, 重组, Low Endotoxin, Azide Free, Validated, ExactAb™, ≥90%(SDS-PAGE&SEC), Lot by Lot |
1167985-17-2 |
100μg
|
¥ 759.9
|
现货 |
阿拉丁 |